{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:28:12Z","timestamp":1790188092152,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA093373"],"award-info":[{"award-number":["P30CA093373"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R21 EY031108"],"award-info":[{"award-number":["R21 EY031108"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY032238"],"award-info":[{"award-number":["R01 EY032238"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013884","name":"Macula Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.omtn.2022.04.015","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T22:17:58Z","timestamp":1651011478000},"page":"613-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization"],"prefix":"10.1016","volume":"28","author":[{"given":"Sook Hyun","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ni","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therlinder","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Lent-Schochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-9419","authenticated-orcid":false,"given":"Ratheesh K.","family":"Meleppat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Zawadzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-3310","authenticated-orcid":false,"given":"Glenn","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.04.015_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1586\/17512433.2014.890047","article-title":"Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis","volume":"7","author":"Todorich","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.omtn.2022.04.015_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/164_2016_78","article-title":"Anti-angiogenic therapy for retinal disease","volume":"242","author":"Paulus","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.omtn.2022.04.015_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2022.04.015_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.exer.2005.05.007","article-title":"Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration","volume":"82","author":"Bhutto","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2022.04.015_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ophtha.2015.09.002","article-title":"Intravitreal bevacizumab versus ranibizumab for treatment of neovascular age-related macular degeneration: findings from a cochrane systematic review","volume":"123","author":"Solomon","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2022.04.015_bib6","first-page":"CD011346","article-title":"Aflibercept for neovascular age-related macular degeneration","volume":"2016","author":"Sarwar","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.omtn.2022.04.015_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.2016.117","article-title":"Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study","volume":"28","author":"Campochiaro","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2022.04.015_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a randomized clinical trial: safety and post hoc analysis of subretinal rAAV.sFLT-1 for wet age-related macular degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2022.04.015_bib9","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(15)00345-1","article-title":"Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial","volume":"386","author":"Rakoczy","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2022.04.015_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oret.2017.09.015","article-title":"Genome editing in retinal diseases using CRISPR technology","volume":"2","author":"Yiu","year":"2018","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.omtn.2022.04.015_bib11","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1167\/iovs.16-20296","article-title":"Genomic disruption of VEGF-A expression in human retinal pigment epithelial cells using CRISPR-cas9 endonuclease","volume":"57","author":"Yiu","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2022.04.015_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtm.2020.01.006","article-title":"Factors impacting efficacy of AAV-mediated CRISPR-based genome editing for treatment of choroidal neovascularization","volume":"17","author":"Chung","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2022.04.015_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41467-017-00140-3","article-title":"Genome editing abrogates angiogenesis in\u00a0vivo","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.04.015_bib14","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1038\/ncomms14500","article-title":"In\u00a0vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.04.015_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtn.2017.08.016","article-title":"In\u00a0vivo knockout of the Vegfa gene by lentiviral delivery of CRISPR\/Cas9 in mouse retinal pigment epithelium cells","volume":"9","author":"Holmgaard","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2022.04.015_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","article-title":"Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice","volume":"5","author":"Ling","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2022.04.015_bib17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","article-title":"Clustered regularly interspaced short palindromic repeats-based genome surgery for the treatment of autosomal dominant retinitis pigmentosa","volume":"125","author":"Tsai","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2022.04.015_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2022.04.015_bib19","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1074\/jbc.271.13.7788","article-title":"The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency","volume":"271","author":"Keyt","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2022.04.015_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2022.04.015_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gr.219089.116","article-title":"Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration","volume":"27","author":"Kim","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2022.04.015_bib22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1167\/iovs.16-20537","article-title":"Editing VEGFR2 blocks VEGF-induced activation of akt and tube formation","volume":"58","author":"Huang","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2022.04.015_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11030-006-9027-3","article-title":"Molecular and functional diversity of vascular endothelial growth factors","volume":"10","author":"Yamazaki","year":"2006","journal-title":"Mol. Divers."},{"key":"10.1016\/j.omtn.2022.04.015_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/107327480200902S05","article-title":"Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers","volume":"9","author":"Rosen","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.omtn.2022.04.015_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ymthe.2016.10.008","article-title":"Improved intravitreal AAV-mediated inner retinal gene transduction after surgical internal limiting membrane peeling in cynomolgus monkeys","volume":"25","author":"Takahashi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.04.015_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1242\/jcs.113.1.59","article-title":"Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation","volume":"113","author":"Carlevaro","year":"2000","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtn.2022.04.015_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","article-title":"VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier","volume":"195","author":"Saishin","year":"2003","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.omtn.2022.04.015_bib28","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","article-title":"Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"118","author":"Shah","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2022.04.015_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2022.04.015_bib30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)61231-X","article-title":"Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function","volume":"167","author":"Marneros","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2022.04.015_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2220\/biomedres.39.287","article-title":"Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral\u00a0nerve regeneration","volume":"39","author":"Nishida","year":"2018","journal-title":"Biomed. Res."},{"key":"10.1016\/j.omtn.2022.04.015_bib32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ajpath.2013.05.011","article-title":"Short hairpin RNA-mediated knockdown of VEGFA in Muller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity","volume":"183","author":"Wang","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2022.04.015_bib33","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1172\/JCI65157","article-title":"Targeted deletion of Vegfa in adult mice induces vision loss","volume":"122","author":"Kurihara","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2022.04.015_bib34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ophtha.2014.11.007","article-title":"Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"122","author":"Grunwald","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2022.04.015_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","article-title":"Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Grunwald","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2022.04.015_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymthe.2018.10.009","article-title":"Long-term effects of in\u00a0vivo genome editing in the mouse retina using Campylobacter jejuni Cas9 expressed via adeno-associated virus","volume":"27","author":"Jo","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.04.015_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nbt.3101","article-title":"Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases","volume":"33","author":"Frock","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2022.04.015_bib38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nprot.2016.043","article-title":"Detecting DNA double-stranded breaks in mammalian genomes by linear amplification-mediated high-throughput genome-wide translocation sequencing","volume":"11","author":"Hu","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2022.04.015_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12864-018-4561-9","article-title":"UDiTaS, a genome editing detection method for indels and genome rearrangements","volume":"19","author":"Giannoukos","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.omtn.2022.04.015_bib40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.molcel.2014.08.002","article-title":"Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining","volume":"55","author":"Ghezraoui","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2022.04.015_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2022.04.015_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1039\/C8BM00637G","article-title":"Intracellular delivery and biodistribution study of CRISPR\/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles","volume":"7","author":"Li","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.omtn.2022.04.015_bib43","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41565-019-0539-2","article-title":"A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in\u00a0vivo genome editing","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2022.04.015_bib44","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1093\/nar\/gkz605","article-title":"Delivering Cas9\/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient \u2018hit-and-run\u2019 genome editing","volume":"47","author":"Lyu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.04.015_bib45","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nbt.3245","article-title":"Photoactivatable CRISPR-Cas9 for optogenetic genome editing","volume":"33","author":"Nihongaki","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2022.04.015_bib46","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1073\/pnas.1912220117","article-title":"Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing","volume":"117","author":"Chen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtn.2022.04.015_bib47","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/hum.2019.021","article-title":"Utility of self-destructing CRISPR\/Cas constructs for targeted gene editing in the retina","volume":"30","author":"Li","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2022.04.015_bib48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/hum.2020.281","article-title":"Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes","volume":"32","author":"Chung","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2022.04.015_bib49","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/nprot.2016.065","article-title":"Isolation, culture and characterization of primary mouse RPE cells","volume":"11","author":"Fernandez-Godino","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2022.04.015_bib50","doi-asserted-by":"crossref","first-page":"126005","DOI":"10.1117\/1.JBO.20.12.126005","article-title":"In\u00a0vivo wide-field multispectral scanning laser ophthalmoscopy-optical coherence tomography mouse retinal imager: longitudinal imaging of ganglion cells, microglia, and Muller glia, and mapping of the mouse retinal and choroidal vasculature","volume":"20","author":"Zhang","year":"2015","journal-title":"J.\u00a0Biomed. Opt."},{"key":"10.1016\/j.omtn.2022.04.015_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nbt.3534","article-title":"Open-source guideseq software for analysis of GUIDE-seq data","volume":"34","author":"Tsai","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2022.04.015_bib52","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"10.1016\/j.omtn.2022.04.015_bib53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2022.04.015_bib54","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122000919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122000919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:54:25Z","timestamp":1778838865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253122000919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":54,"alternative-id":["S2162253122000919"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.04.015","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}